Menu
Find People
Find Everything
About This Site
Edit My Profile
Login to Profiles
DIRECT2Experts
Help / FAQ
History
The Relationships Amon
Principal Investigator
Principal Investigator
Determination of pepti
COX-2 inhibitors and c
See All (13) pages
Keywords
Last Name
Institution
@uada.edu
@ualr.edu
@uapb.edu
@uark.edu
University of Arkansas for Medical Sciences
More Search Options
Announcement
You can now add alternative names!
Click here
to add other names that you've published under.
COX-2 inhibitors and cardiovascular risk. Inferences based on biology and clinical studies.
Marwali MR, Mehta JL. COX-2 inhibitors and cardiovascular risk. Inferences based on biology and clinical studies. Thromb Haemost. 2006 Oct; 96(4):401-6.
View in:
PubMed
subject areas
Animals
Blood Platelets
Cardiovascular Diseases
Cyclooxygenase 2
Cyclooxygenase 2 Inhibitors
Diclofenac
Drug Labeling
Endothelium, Vascular
Epoprostenol
Humans
Lactones
Platelet Aggregation
Product Surveillance, Postmarketing
Pyrazoles
Randomized Controlled Trials as Topic
Risk Assessment
Sulfonamides
Sulfones
Thromboxane A2
authors with profiles
Jawahar Mehta